’DALLAS, March 18, 2026 — Spectral AI, Inc. MDAI (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in…
Spectral AI: Zacks maintains $5 valuation and expects mid-2026 FDA decision
https://scr.zacks.com/news/news-details/2026/MDAI-In-the-Blocks-Ready-to-Go-upon-Mid-Year-Authorization-article/default.aspx The principle new information here for me is greater clarity on average FDA timescales for a decision on Spectral AI’s DeepView system. Notably ‘Based on historical data, a De…
Spectral AI: First of Its Kind Automated Wound Healing Prediction
Spectral AI: First of Its Kind Automated Wound Healing Prediction Overview Spectral AI is an artificial intelligence business offering predictive wound diagnostics designed to facilitate faster and more accurate treatment…